Veeva Systems (VEEV) investor relations material

Business overview and growth

• Focused on building an industry cloud for life sciences, with applications, agents, data, and consulting integrated across commercial, R&D, and quality areas.

• Portfolio expanded from 15 to over 50 products in 10 suites, with accelerated AI innovation in the last 18 months.

• Core business continues strong execution, with services achieving their highest growth in two years.

AI strategy and product innovation

• Adopted a patient approach to AI, prioritizing reliability and value in highly regulated environments.

• Vault AI agents enhance productivity within applications, while Falcon agents aim to automate end-to-end workflows, reducing manual labor and increasing speed.

• Falcon is expected to be embedded across all product areas, with early adopters in clinical, quality, regulatory, and commercial content.

• Acquisitions like Copli and Ostro accelerate specific capabilities, but organic development remains the main strategy.

Monetization and pricing

• Vault AI uses a consumption-based pricing model, while Falcon is likely to be priced per business transaction, such as document review or inquiry resolution.

• Pricing strategies are evolving, focusing on product excellence and high-margin opportunities by delivering clear business value.